Completed OBSERVATIONAL NCT04463706

COVID19 Severity Prediction and Health Services Research Evaluation

Clinical Characterization of CoVid19 Infection: Prognostic Stratification and Complications

Sponsor: Biobizkaia Health Research Institute

Conditions Covid19

Interventions Predictors adverse evolution Predictors of health care provide

Updated 8 times since 2020 Last updated: Feb 27, 2024 Started: Jun 1, 2020 Primary completion: Dec 30, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Biobizkaia Health Research Institute leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Completed
Sep 2024 — Feb 2026 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2024 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Oct 2023 — Mar 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Oct 2021 — Oct 2023 [monthly]

Recruiting
Jan 2021 — Oct 2021 [monthly]

Recruiting
Aug 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biobizkaia Health Research Institute
Hospital Costa del Sol
Hospital Donostia
Hospital Galdakao-Usansolo
Hospital Universitario Araba
Hospital de Basurto
Hospital del Mar
Instituto de Salud Carlos III
University Hospital of the Nuestra Señora de Candelaria

Data source: Hospital Galdakao-Usansolo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Galdakao, Spain